摘要
目的探讨阿托伐他汀钙片对急性脑梗死患者神经功能缺损疗效。方法选取2018年1~12月急性脑梗死患者84例为研究对象,按治疗方式不同分为对照组和观察组各42例。对照组给予常规治疗,观察组给予阿托伐他汀钙片,比较两组患者治疗效果。结果观察组NIHSS评分、血脂水平、炎性因子低于对照组,认知功能评分高于对照组,差异均有统计学意义(P<0.05)。两组患者不良反应发生率比较差异无统计学意义(P>0.05)。结论阿托伐他汀钙片可有效改善急性脑梗死患者神经功能缺损症状,治疗效果显著。
Objective To analyze the efficacy of atorvastatin calcium tablets on neurological deficits in patients with acute cerebral infarction. Methods Eighty-four patients with acute cerebral infarction from January 2018 to December 2018 were enrolled in the study. All them were divided into control group and observation group according to different treatment methods, 42 cases in each group. The control group was given conventional treatment, and the observation group was given atorvastatin calcium tablets. The therapeutic effects of the two groups were compared. Results The NIHSS score, blood lipid level and inflammatory factor of the observation group were lower than those of the control group, the cognitive function score of the observation group was higher than that of the control group, all the differences were statistically significant (P < 0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P > 0.05). Conclusion Atorvastatin calcium tablets can effectively improve the symptoms of neurological deficits in patients with acute cerebral infarction, and the treatment effect is remarkable.
作者
邢贞国
XING Zhenguo(Department of Neurology, the People’s Hospital of Linkou County, Linkou 157600, China)
出处
《中国医药科学》
2019年第12期232-234,共3页
China Medicine And Pharmacy
关键词
阿托伐他汀钙片
急性脑梗死
神经功能缺损
Atorvastatin calcium tablets
Acute cerebral infarction
Neurological deficit